CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 430 enrolled
Drug / intervention
Discontinuing antibiotic therapy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02900820
NCT02900820N/ACompleted

Safety of Discontinuing Patient Antibiotic Treatment When Physicians no Longer Consider it Necessary

Spanish Society of Family and Community Medicine·interventional·Posted Sep 14, 2016·Updated Sep 21, 2021

In Brief

A clinical study evaluating Discontinuing antibiotic therapy and Continuing antibiotic therapy for Infectious Diseases and Respiratory Tract Infections. Completed, enrolled 430 participants across 5 sites.

Detailed Summary

There is no evidence that discontinuing antibiotic therapy for non-bacterial infections is safe. The main objective of this study is to determine whether discontinuation of antibiotic therapy when a clinician no longer considers it necessary makes any difference in terms of the number of days with severe symptoms. This is a multicentre, open-label, randomised controlled clinical trial. The study will be conducted in ten primary care centres in Spain. We will include patients from 18 to 75 years of age with uncomplicated acute respiratory tract infections (RTIs) in whom: antibiotics are not necessary; or those diagnosed with clinical conditions for which antibiotics might be necessary but according to the history and clinical examination the physician considers that antibiotics are not needed or the patient feels that the antibiotic regimen has not worked as expected; or several doses of an antibiotic have been taken from leftovers found in the household or obtained at the pharmacy without any medical prescription for a clinical condition for which antibiotics are not necessary. The patients will be randomly assigned to the usual strategy of continuing antibiotic treatment (usual intervention group) or discontinuing antibiotic therapy (novel intervention group). A sample size of 215 patients per group was calculated on the basis of a reduction of one day in the duration of severe symptoms as a clinically relevant outcome. The primary outcome will be duration of severe symptoms, i.e. symptoms scored 5 or 6 by means of a symptom diary. Secondary outcomes will include: antibiotics taken, adverse events, patient satisfaction, and complications within the first 3 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 14, 2016
Enrollment StartJan 1, 2017
Primary CompletionJun 1, 2020
Study CompletionDec 1, 2020
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 9.8 years ago

Interventions

Discontinuing antibiotic therapyother

Patients assigned to this group will be asked to discontinue antibiotic therapy.

Continuing antibiotic therapyother

Patients assigned to this group will be asked to complete antibiotic therapy.